Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07178990

Mobile Platform for Optimizing Wellness and Engagement in Recovery

This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Opioid Agonist Treatment Alcohol Use Disorder Alcohol-Related Disorders Alcoholism Chemically-Induced Disorders Mental Disorders Narcotic-Related Disorders Opioid Use Disorder Opioid-Related Disorders Substance-Related Disorders

Age range

19 year–63 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location status: Recruiting

Location contact

Anne Fernandez, PhD

PRINCIPAL_INVESTIGATOR

Haley Stevens

CONTACT

[email protected]

734-764-9910

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants must be enrolled in the Michigan Medicaid program
  • Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
  • Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
  • Participants must have regular access to a working smartphone and internet connection.
  • Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).

Exclusion criteria

  • Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group
  • Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
  • Individuals with substantial cognitive impairment that would interfere with study participation
  • Individuals unable to read or understand English
  • Individuals experiencing active suicidality or psychosis.
  • Individuals with a planned admission to residential treatment or incarceration during the study period.

Treatment and study plan

Digital Contingency Management Intervention Arm

Behavioral

Participants will use a version of the app for 6-months. Participants in this group may earn rewards for completing recovery-related activities and for abstinence from drugs and alcohol. During the 6 months this will include: random saliva drug tests, breathalyzer tests, and video selfies, completing surveys and questionnaires through the app, and receiving rewards on a debit card for abstinent tests, surveys, and activities. Additionally, participants will complete follow-up at approximately 9 months after randomization.

Digital Wellness Arm

Behavioral

Participants will use a version of the app for 6-months focussed on wellness. During the 6 months this will include: random requests to do saliva drug tests, breathalyzer tests, and video selfies, complete surveys and questionnaires through the app, and receive rewards on a debit card for completing tests, surveys, and activities. Participants in this group may also earn rewards for completing study activities like tests and surveys. Additionally, participants will complete follow-up at approximately 9 months after randomization.

Primary outcomes

  1. Feasibility based on recruitment

    Time frame: Recruitment period 12 months

    Recruitment: ≥60% of participants enrolled

  2. Feasibility based on adherence

    Time frame: 6 months (during the Dynamicare program)

    Adherence: ≥50% of app-based, biochemically-verified tests completed in the digital CM condition.

  3. Feasibility based on Retention

    Time frame: 6 months

    Retention: ≥70% of participants retained at 6 months

  4. Acceptability of the intervention

    Time frame: 3-month after starting program

    Defined as >70% of participants rating the intervention experience ≥ 4/5 on the Acceptability of Intervention Measure

Study contacts

Contact information is provided by the study sponsor or research team.

Haley Stevens

CONTACT

[email protected]

734-764-9910

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • DynamiCare Health
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Registry information

Acronym: MPOWER

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Sep 17, 2025
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.